TPG is considering a potential sale of Lyric, a healthcare payments software firm, for approximately $5 billion, amid recovering M&A activity in the software sector.

UK · 2026-09-10

1. Step 1 · The triggerTPG explores a $5bn sale of Lyric, a major healthcare payments software asset, as M&A activity recovers in the US software sector.
2. Step 2 · Knock-onThe marketing and potential sale of Lyric at a high valuation resets benchmarks for healthcare payments software, raising exit expectations for comparable firms in the US and UK.
3. Step 3 · Reaches youUK SMEs in healthtech see buyer appetite and competitive dynamics shift, affecting their own valuation, partnership, and exit prospects.

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: Private Equity Wire

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.